Leiden/Amsterdam Center for Drug Research (LACDR), Division of Medicinal Chemistry, Department of Pharmacochemistry, Faculty of Exact Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands.
Curr Top Med Chem. 2011;11(6):661-79. doi: 10.2174/1568026611109060661.
The deorphanization of the histamine H₄ receptor (H₄R) has led to a significant number of scientific publications and patent applications. Whereas some histamine H₁, H₂ and H₃ receptor ligands were found to have significant affinity for H₄R, several agonists and antagonists with high affinity for H₄R and selectivity over the other histamine receptors were successfully designed and synthesized. Moreover, site-directed mutation studies on H₄R have been performed and reveal detailed information on receptor-ligand interactions. This review will focus on the most important H₄R ligand scaffolds and their structure-activity relationships and selectivity over other histamine receptors and specific H₄R functional activity. Experimental data are used to construct and validate high resolution three-dimensional receptor-ligand models and, vice versa, in silico models are used to design and rationalize experimental studies to probe receptor-ligand interactions.
组胺 H₄ 受体(H₄R)的非孤儿化导致了大量的科学出版物和专利申请。虽然一些组胺 H₁、H₂ 和 H₃ 受体配体被发现对 H₄R 具有显著的亲和力,但成功设计和合成了一些对 H₄R 具有高亲和力和对其他组胺受体具有选择性的激动剂和拮抗剂。此外,还对 H₄R 进行了定点突变研究,揭示了受体-配体相互作用的详细信息。这篇综述将重点介绍最重要的 H₄R 配体支架及其结构-活性关系,以及对其他组胺受体和特定 H₄R 功能活性的选择性。实验数据用于构建和验证高分辨率的三维受体-配体模型,反之亦然,计算模型用于设计和合理化实验研究以探测受体-配体相互作用。